Muhamad Amza Ali
Founder chez Psyence Therapeutics Corp.
Profil
Muhamad Amza Ali is the founder and Chief Medical Officer of Psyence Therapeutics Corp.
which is founded in 2020.
He is currently the Head of Neurosciences Research at The University of the West Indies since 2016 and also serves as the President of the Caribbean Chapter at the International League Against Epilepsy.
Dr. Ali was the Director and Chief Medical Officer at Psyence Group, Inc. from 2021 to 2022 and was the Chief Medical Officer at Avicanna, Inc. from 2019 to 2021.
He holds an MBA from Rotman School of Management (2016), a graduate degree from Henley Business School Ltd.
(2017), and an undergraduate degree from The University of the West Indies (1984).
Postes actifs de Muhamad Amza Ali
Sociétés | Poste | Début |
---|---|---|
International League Against Epilepsy | Corporate Officer/Principal | - |
Psyence Therapeutics Corp. | Founder | 01/04/2020 |
The University of the West Indies | Corporate Officer/Principal | 01/09/2016 |
Anciens postes connus de Muhamad Amza Ali
Sociétés | Poste | Fin |
---|---|---|
PSYENCE GROUP INC. | Chief Tech/Sci/R&D Officer | 01/09/2022 |
AVICANNA INC. | Chief Tech/Sci/R&D Officer | 01/01/2021 |
Formation de Muhamad Amza Ali
Rotman School of Management | Masters Business Admin |
Henley Business School Ltd. | Graduate Degree |
The University of the West Indies | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
AVICANNA INC. | Health Technology |
PSYENCE GROUP INC. | Industrial Services |
Entreprise privées | 2 |
---|---|
International League Against Epilepsy | |
Psyence Therapeutics Corp. |